SCHEMBL4623973

SCHEMBL4623973

COC(=O)C(Cc1ccc2nc(-c3c(Cl)cccc3Cl)ccc2c1)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.51
ITGAV P06756 1/20 0.51
TACR1 P25103 6/20 0.38
ITGA4 P13612 2/20 0.38
ITGB7 P26010 2/20 0.38
ABL1 P00519 1/20 0.38
CDK2 P24941 1/20 0.35
GAA P10253 1/20 0.35
CTSV O60911 2/20 0.34
CTSL P07711 2/20 0.34
CTSS P25774 2/20 0.34
TACR3 P29371 1/20 0.34
CTSK P43235 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3316799 0.86 ITGB1 (0.53) ITGB1ITGAVTACR1ITGA4ITGB7
SCHEMBL3314316 0.86 ITGB1 (0.53) ITGB1ITGAVTACR1ITGA4ITGB7
SCHEMBL4625418 0.85 ITGB1 (0.44) ITGB1ITGAVTACR1ITGA4ITGB7
SCHEMBL4625486 0.82 ITGB1 (0.50) ITGB1ITGAVITGA4ITGB7ABL1
SCHEMBL3316735 0.82 ITGB1 (0.50) ITGB1ITGAVTACR1ITGA4ITGB7
SCHEMBL3313318 0.80 ITGB1 (0.51) ITGB1ITGAVTACR1ITGA4ITGB7
SCHEMBL13398361 0.80 ITGB1 (0.53) ITGB1ITGAVITGA4ITGB7ABL1
SCHEMBL13398408 0.80 ITGB1 (0.47) ITGB1ITGAVTACR1L3MBTL1
SCHEMBL8349099 0.80 ITGB1 (0.47) ITGB1ITGAVTACR1L3MBTL1
SCHEMBL4410500 0.79 ITGB1 (0.53) ITGB1ITGAVITGA4ITGB7L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP disclosed
EP-1870402-A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors UCB Pharma, S.A. (BE) 2007-12-26 EP disclosed